| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0052 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |